- Armand Rossetti | November 25, 2008 2:32 PM |
Category:
Defective & Dangerous ProductsDoctors have been associating catheter delivered intra-articular pain pump anesthesia with cartilage cell toxicity. It has now become increasingly evident that pain pump infused anesthesia is...
- Brenda Fulmer | November 24, 2008 3:36 PM |
Category:
FDA & Prescription DrugsFinancial sources are reporting that Johnson & Johnson paid nearly $69 million in confidential settlement payments to resolve several hundred Ortho Evra claims in the first quarter of 2008....
- Armand Rossetti | November 21, 2008 4:13 PM |
Category:
Defective & Dangerous ProductsOn October 12, 2007, Biomedical Innovation headlined, “I-Flow faces lawsuits, defends its pain pump.” In that story, Orlando Rodriguez, vice President of marketing at I-Flow indicated...
- Brenda Fulmer | November 20, 2008 4:08 PM |
Category:
FDA & Prescription DrugsCongressmen John Dingell and Bart Stupak, members of the House Energy and Commerce Committee, have questioned the FDA Commissioner about the ability of the Agency to conduct adequate safety...
- Armand Rossetti | November 20, 2008 3:21 PM |
Category:
Defective & Dangerous ProductsThe FDA directs the Center for Devices and Radiologic Health (CDRH), which is The Office in charge of regulating medical devices. Recently, a group of scientists who review device safety at the...
- Brenda Fulmer | November 19, 2008 1:16 PM |
Category:
FDA & Prescription DrugsThose of us who have personally seen the devastating impact of diabetes in our own lives and those of our loved ones are always looking for the next great drug that might provide hope to our...
- Brenda Fulmer | November 18, 2008 1:37 PM |
Category:
Medical Devices & ImplantsOn November 20, 2008, the Judicial Panel for Multidistrict Litigation will convene in Charleston to hear arguments on whether multi-district litigation should be established for the management of...
- Armand Rossetti | November 16, 2008 3:43 PM |
Category:
Defective & Dangerous ProductsIn May 2006, the Food and Drug Administration (FDA) approved Pfizer’s Chantix (varenicline tartrate), a smoking cessation drug. Reportedly under priority review, the FDA had cut the usual...
- Armand Rossetti | November 14, 2008 2:30 PM |
Category:
Defective & Dangerous ProductsSometimes searching for information has to occur outside the box. For example, who would have thought that a scholarly paper about eye drops would contain information central to understanding how...
- Armand Rossetti | November 13, 2008 5:08 PM |
Category:
Defective & Dangerous ProductsPlease watch the Fluoroquinolone Toxicity Research Foundation’s video entitled A Prescription for Disaster.
Two drugs, Cipro and Levaquin, belonging to the fluoroquinolone (Floxacin)...
- Armand Rossetti | November 13, 2008 9:54 AM |
Category:
FDA & Prescription DrugsYesterday, the FDA released an update about the agency’s safety data review, regarding the increased risk of atrial fibrillation in patients treated with seven available bisphosphonate...
- Armand Rossetti | November 12, 2008 9:49 AM |
Category:
Defective & Dangerous ProductsAccording to Sharon Bourke, et al., authors of a paper entitled, “A Photo-Cross-linked Poly(vinyl Alcohol) Hydrogel Growth Factor Release Vehicle for Wound Healing Applications” that...
- Armand Rossetti | November 11, 2008 1:25 PM |
Category:
Defective & Dangerous ProductsRegranex is a prescription gel that diabetic patients apply directly to foot and leg ulcers. On June 6, 2008, The Food and Drug Administration (FDA) posted a follow up communication about their...
- Armand Rossetti | November 10, 2008 11:20 AM |
Category:
Defective & Dangerous ProductsOn November 7, 2008 San Francisco’s 1st District Court of Appeal ruled that original brand name drug makers can now be held liable for injuries that competing generic drug companies cause when...
- Armand Rossetti | November 10, 2008 9:28 AM |
Category:
Defective & Dangerous ProductsIntroduction:
For example, the Prohance brand of Gadolinium is more stable than and clears more completely than the Omniscan brand of Gadolinium. This difference in stability is due to the...
- Armand Rossetti | November 07, 2008 10:51 AM |
Category:
Defective & Dangerous ProductsIn its natural form, chondroitin sulfate (itself a glycosaminoglycan) is used as a natural dietary supplement for the palliation of osteoarthritis. In fact, natural chondroitin sulfate is not a...
- Armand Rossetti | November 06, 2008 11:50 AM |
Category:
Medical Devices & ImplantsOn October 20, 2008, The FDA issued a dear healthcare practitioner notice, concerning complications associated with transvaginal placement of surgical mesh for certain procedures. The notification...
- Armand Rossetti | November 06, 2008 8:41 AM |
Category:
Medical Devices & ImplantsTension free vaginal tape (TVT) is a relatively narrow strip of propylene mesh tape [1.1 cm (1/2 inch) X 40 cm (14 inches)] with two stainless steel needles, one at each end that surgeons insert at...
- Armand Rossetti | November 05, 2008 11:04 AM |
Category:
Defective & Dangerous ProductsShould the FDA establish an Intellectual Property Committee (IPC) to oversee licensing and distribution of pharmaceutical and medical device intellectual property?
The following discussion...
- Brenda Fulmer | November 05, 2008 8:59 AM |
Category:
FDA & Prescription Drugs
C. R. Bard, is a leader in the manufacture of surgical mesh products and other medical devices used in the areas of vascular and general surgery, urology, and oncology. Bard now faces significant...
- Brenda Fulmer | November 04, 2008 6:18 AM |
Category:
FDA & Prescription Drugs
Judge Joseph R. Goodwin, a federal judge in Charleston, West Virginia, has been selected to oversee pre-trial coordination of the Digitek litigation. Judge Goodwin will hold the first hearing to...
- Armand Rossetti | November 02, 2008 3:38 PM |
Category:
FDA & Prescription DrugsByetta (exenatide) is an analogue of glucagon-like peptide (GLP-1) derived from the saliva of a Gila monster. Injected twice daily an hour before meals, the drug mimics GLP-1 and enhances insulin...
- Armand Rossetti | November 02, 2008 11:10 AM |
Category:
FDA & Prescription DrugsReporters at The Wall Street Journal (WSJ) have been paying close attention to recent developments concerning federal preemption of state lawsuits, concerning United States Food and Drug...